doi: 10.1093/jnci/96.17.1268.
Medicare cost containment strategy targets several oncology drugs
- PMID: 15339960
- DOI: 10.1093/jnci/96.17.1268
Item in Clipboard
Medicare cost containment strategy targets several oncology drugs
J Natl Cancer Inst.
.
No abstract available
Similar articles
-
Medicare and drug pricing.N Engl J Med. 2003 Apr 17;348(16):1590-7. doi: 10.1056/NEJMhpr035135. N Engl J Med. 2003. PMID: 12700381 No abstract available.
-
Prescription drug prices in Canada.Issue Brief (Public Policy Inst (Am Assoc Retired Pers)). 2003 Jun;(IB62):1-22. Issue Brief (Public Policy Inst (Am Assoc Retired Pers)). 2003. PMID: 12807123 No abstract available.
-
Limits on Medicare's ability to control rising spending on cancer drugs.N Engl J Med. 2009 Feb 5;360(6):626-33. doi: 10.1056/NEJMhpr0807774. Epub 2009 Jan 27. N Engl J Med. 2009. PMID: 19176475 No abstract available.
-
Molecular medicine, the Medicare drug benefit, and the need for cost control.J Am Geriatr Soc. 2006 Sep;54(9):1442-6. doi: 10.1111/j.1532-5415.2006.00845.x. J Am Geriatr Soc. 2006. PMID: 16970656 Review.
-
European perspective on the costs and cost-effectiveness of cancer therapies.J Clin Oncol. 2007 Jan 10;25(2):191-5. doi: 10.1200/JCO.2006.07.8956. J Clin Oncol. 2007. PMID: 17210939 Review.
Cited by
-
Using informatics to improve cancer surveillance.J Am Med Inform Assoc. 2020 Jul 1;27(9):1488-1495. doi: 10.1093/jamia/ocaa149. J Am Med Inform Assoc. 2020. PMID: 32941600 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
